Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Cowen Weighs in on Kite Pharma (KITE) Following One Fatal Cerebral Edema Case
-
Kite Pharma (KITE) Being Defended At Cowen & Co.
-
Kite Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Cowen Reiterates Outperform Rating on Kite Phara (KITE) Following Dinner with Senior Management; 'Remains a Top Pick'
-
Kite to Present at March 2017 Investor Conferences
-
Kite Pharma (KITE) Prices 4.75M Shares at $75
-
Kite Announces Pricing of Public Offering of Common Stock
-
Kite Pharma to Present at March 2016 Investor Conferences
-
Kite Pharma (KITE) Says Underwriter Exercised Full Option to Purchase Additional Shares
-
Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Kite Pharma (KITE) Prices 3.625M Shares Offering at $69
-
Kite Pharma Announces Pricing of Public Offering of Common Stock
-
Kite Pharma (KITE) Commences $250M Common Stock Offering
-
Kite Pharma Announces Proposed Public Offering of Common Stock
-
Kite Pharma Announces Proposed Public Offering of Common Stock
-
Kite Pharma (KITE) Bullish View Reiterated at Cowen as Enrollment in KTE-C19 Phase II Trial Opens
-
Pre-Open Stock Movers 08/14: (JCP) (WX) (JWN) Higher; (LOCO) (KING) (AAVL) Lower (more...)
-
Buy Kite Pharma (KITE) on Weakness Related to Patient Death, Cowen Says
-
Cowen Reiterates Bullish Stance on Kite Pharma (KITE) Following Investor Day
-
Kite Pharma's (KITE) Acqusition Called 'Excellent' at Cowen
-
Kite Pharma (KITE) Bullish Stance Reiterated at Cowen Following Management Luncheon
-
Kite Pharma (KITE) Prices 3.49M Common Follow-On Offering at $54/Share
-
Kite Pharma Announces Pricing of Follow-On Offering
-
Cowen Starts Kite Pharma (KITE) at Outperform
-
Kite Pharma (KITE) IPO Surges Higher
-
Kite Pharma (KITE) Prices 7.5M Common IPO at $17/Share
-
Kite Pharma (KITE) Files $115M IPO

